During early 2021, EU Commission President Ursula von der Leyen engaged in intense negotiations with Pfizer's CEO Albert Bourla to secure billions of Covid vaccine doses as the pandemic escalated. With the EU struggling in its vaccination efforts compared to the UK and Israel, and faced with supply issues from various pharmaceutical companies, von der Leyen orchestrated a deal to purchase up to 1.8 billion doses from Pfizer. Despite her success, questions arose regarding the terms of the deal and the absence of transparency after the EU refused to release communications related to the contract negotiations.
The EU spent 21.5bn on an exclusive deal with Pfizer for up to 1.8bn doses, highlighting the commission's frenzied effort to secure vaccines during the pandemic.
The refusal to disclose messages exchanged between Ursula von der Leyen and Albert Bourla raises questions about transparency and public accountability in vaccine negotiations.
Collection
[
|
...
]